Camber Specialty will support the increasing demand for these products by providing hospitals, clinics, government facilities, and other institutional partners more high-quality generic choices. The company’s parent company, Hetero Labs, has made a commitment to launching a deep pipeline of Specialty products with dosage forms that include injectable, ophthalmic, infusion, and specialty oral solids.
Hetero is a global supplier of critical care products including those used as rare disease therapies. Oncology care remains at the heart of the organization’s goals for future products. The company has a deep pipeline of products for the treatment cancer, based in the therapeutic Oncology class of drugs. Our institutional partners will have the strength of Camber, a leading generic company, focusing its resources on bringing to market important generic injectable molecules.
Company Details
- Founded
- 2022
- Address
- 800 Centennial Avenue, Suite 1, Piscataway,new Jersey 08854,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- specialty pharmaceuticals, medical distribution, sales and marketing, drug development, Injectable medications, oncology medications.
- HQ
- Piscataway, New Jersey
Camber Specialty Questions
Camber Specialty's website is https://www.camberpharma.com/specialty/
Camber Specialty's LinkedIn profile is https://www.linkedin.com/company/camber-specialty
Camber Specialty's industry is
Pharmaceutical Manufacturing
Camber Specialty's top competitors are
Camber Pharmaceuticals Inc,
Camber Pharmaceuticals Inc. - Ph,
Wg Criticalcare,
Avet Pharmaceuticals Inc.,
Aurobindo Pharma Usa, Inc.,
Hetero,
Amneal Pharmaceuticals,
Pharmasphere,
Rising Pharmaceuticals,
Casper Pharma, Llc.
Camber Specialty's categories are Pharmaceutical Manufacturing
Camber Specialty's founding year is 2022
